Continue to site >
Trending ETFs

KraneShares Emerging Markets Healthcare Index ETF

ETF
KMED
Payout Change
Pending
Price as of:
$20.79 -0.33 -1.56%
primary theme
Emerging Markets Equity
KMED (ETF)

KraneShares Emerging Markets Healthcare Index ETF

Payout Change
Pending
Price as of:
$20.79 -0.33 -1.56%
primary theme
Emerging Markets Equity
KMED (ETF)

KraneShares Emerging Markets Healthcare Index ETF

Payout Change
Pending
Price as of:
$20.79 -0.33 -1.56%
primary theme
Emerging Markets Equity

Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$20.79

$2.26 M

0.52%

$0.11

0.80%

Vitals

YTD Return

-10.7%

1 yr return

-37.1%

3 Yr Avg Return

0.8%

5 Yr Avg Return

N/A

Net Assets

$2.26 M

Holdings in Top 10

38.5%

52 WEEK LOW AND HIGH

$21.1
$20.70
$36.93

Expenses

OPERATING FEES

Expense Ratio 0.80%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 73.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund

Investment Style

Diversified Emerging Mkts


Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$20.79

$2.26 M

0.52%

$0.11

0.80%

KMED - Profile

Distributions

  • YTD Total Return -25.3%
  • 3 Yr Annualized Total Return 0.8%
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio -0.05%
DIVIDENDS
  • Dividend Yield 0.5%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    KraneShares Emerging Markets Healthcare Index ETF
  • Fund Family Name
    KraneShares
  • Inception Date
    Aug 29, 2018
  • Shares Outstanding
    100019
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Jonathan Shelon

Fund Description

The fund will invest at least 80% of its total assets in components of the index, depositary receipts, representing such components, and securities underlying depositary receipts in the index. The underlying index includes companies that RBICS classifies as engaged in the pharmaceuticals, biotechnology, medical specialties, managed health care, hospital/nursing management, medical/nursing services and services to the health industry businesses. The fund is non-diversified.


KMED - Performance

Return Ranking - Trailing

Period KMED Return Category Return Low Category Return High Rank in Category (%)
YTD -10.7% -37.0% 15.7% 17.85%
1 Yr -37.1% -53.7% 52.7% 98.08%
3 Yr 0.8%* -9.4% 15.9% 63.62%
5 Yr N/A* -4.4% 11.4% N/A
10 Yr N/A* -1.5% 9.3% N/A

* Annualized

Return Ranking - Calendar

Period KMED Return Category Return Low Category Return High Rank in Category (%)
2021 -23.0% -86.5% 30.0% 95.21%
2020 61.9% -26.9% 480.0% 1.32%
2019 9.8% -0.7% 42.0% 91.15%
2018 N/A -58.5% 9.4% N/A
2017 N/A -33.4% 66.6% N/A

Total Return Ranking - Trailing

Period KMED Return Category Return Low Category Return High Rank in Category (%)
YTD -25.3% -47.4% 15.7% 91.13%
1 Yr -37.1% -53.7% 48.5% 97.76%
3 Yr 0.8%* -9.4% 15.9% 61.31%
5 Yr N/A* -4.4% 18.6% N/A
10 Yr N/A* -1.5% 9.3% N/A

* Annualized

Total Return Ranking - Calendar

Period KMED Return Category Return Low Category Return High Rank in Category (%)
2021 -23.0% -86.5% 30.0% 95.21%
2020 61.8% -22.1% 480.0% 1.32%
2019 9.8% -0.7% 42.0% 91.15%
2018 N/A -58.5% 10.3% N/A
2017 N/A -33.4% 66.6% N/A

KMED - Holdings

Concentration Analysis

KMED Category Low Category High KMED % Rank
Net Assets 2.26 M 706 K 101 B 99.42%
Number of Holdings 151 7 6618 32.88%
Net Assets in Top 10 869 K 3.68 K 19.1 B 97.42%
Weighting of Top 10 38.47% 3.0% 71.5% 33.22%

Top 10 Holdings

  1. Sun Pharmaceuticals Industries Ltd 6.61%
  2. Sun Pharmaceuticals Industries Ltd 6.61%
  3. Sun Pharmaceuticals Industries Ltd 6.61%
  4. Sun Pharmaceuticals Industries Ltd 6.61%
  5. Sun Pharmaceuticals Industries Ltd 6.61%
  6. Sun Pharmaceuticals Industries Ltd 6.61%
  7. Sun Pharmaceuticals Industries Ltd 6.61%
  8. Sun Pharmaceuticals Industries Ltd 6.61%
  9. Sun Pharmaceuticals Industries Ltd 6.61%
  10. Sun Pharmaceuticals Industries Ltd 6.61%

Asset Allocation

Weighting Return Low Return High KMED % Rank
Stocks
100.05% 0.90% 110.97% 2.02%
Preferred Stocks
0.00% 0.00% 2.63% 84.96%
Other
0.00% -1.85% 10.24% 80.58%
Convertible Bonds
0.00% 0.00% 5.94% 79.80%
Bonds
0.00% -0.03% 57.56% 82.06%
Cash
-0.06% -23.67% 18.92% 95.74%

Stock Sector Breakdown

Weighting Return Low Return High KMED % Rank
Healthcare
98.53% 0.00% 98.53% 0.11%
Basic Materials
0.75% 0.00% 30.36% 96.05%
Consumer Defense
0.72% 0.00% 27.29% 97.63%
Utilities
0.00% 0.00% 39.08% 93.35%
Technology
0.00% 0.00% 44.92% 99.77%
Real Estate
0.00% 0.00% 17.90% 95.83%
Industrials
0.00% 0.00% 44.40% 98.53%
Financial Services
0.00% 0.00% 48.90% 99.77%
Energy
0.00% 0.00% 26.29% 96.96%
Communication Services
0.00% 0.00% 45.83% 99.89%
Consumer Cyclical
0.00% 0.00% 47.03% 99.89%

Stock Geographic Breakdown

Weighting Return Low Return High KMED % Rank
Non US
98.88% -4.71% 112.57% 20.88%
US
1.17% -1.60% 104.72% 40.63%

KMED - Expenses

Operational Fees

KMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.80% 0.01% 2.69% 79.59%
Management Fee 0.78% 0.00% 2.00% 35.64%
12b-1 Fee 0.00% 0.00% 1.00% 10.22%
Administrative Fee N/A 0.01% 0.85% N/A

Sales Fees

KMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

KMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 0.40% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

KMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 73.00% 3.00% 466.00% 70.83%

KMED - Distributions

Dividend Yield Analysis

KMED Category Low Category High KMED % Rank
Dividend Yield 0.52% 0.00% 48.83% 41.58%

Dividend Distribution Analysis

KMED Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Monthly Monthly

Net Income Ratio Analysis

KMED Category Low Category High KMED % Rank
Net Income Ratio -0.05% -1.98% 8.59% 78.25%

Capital Gain Distribution Analysis

KMED Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Dividend Payout History

View More +

KMED - Fund Manager Analysis

Managers

Jonathan Shelon


Start Date

Tenure

Tenure Rank

Aug 29, 2018

3.67

3.7%

Jonathan Shelon, Managing Partner and Chief Operating Officer at Krane, also serves as a portfolio manager of each Fund and supports Mr. Schlarbaum and Krane’s investment team with respect to each Fund. Mr. Shelon has been a portfolio manager of each Fund since August 2018 (in the case of KraneShares CSI China Internet ETF, KraneShares Electric Vehicles and Future Mobility Index ETF, KraneShares Emerging Markets Consumer Technology Index ETF, KraneShares MSCI All China Healthcare Index ETF, KraneShares MSCI All China Index ETF, KraneShares MSCI China Environment Index ETF, KraneShares MSCI One Belt One Road Index ETF and KraneShares Zacks New China ETF) or since inception (in the case of KraneShares Emerging Markets Healthcare Index ETF, KraneShares MSCI All China Consumer Discretionary Index ETF, KraneShares MSCI All China Consumer Staples Index ETF and KraneShares MSCI China A Inclusion Hedged Index ETF,). Mr. Shelon joined Krane in 2015 as a Managing Partner. Mr. Shelon has spent the majority of his career managing investment portfolios and diverse teams at leading asset management organizations. Most recently, he was the Chief Investment Officer of a 40-person global Specialized Strategies Team at J.P. Morgan with $40 billion AUM. Prior to joining J.P. Morgan, Mr. Shelon spent ten years as a portfolio manager at Fidelity Investments since 2001 where he was responsible for the investment performance, process and evolution of their target-date strategies for retirement savings, college savings and income generation. Prior to joining, he was a quantitative consultant at Callan Associates, Inc.

James Maund


Start Date

Tenure

Tenure Rank

Jan 14, 2020

2.29

2.3%

James Maund, Head of Capital Markets at Krane Funds Advisors LLC. He joined the Krane Funds Advisors in 2020 and has been in the investment management industry since 2005. Previously, he was a Vice President in the Institutional ETF Group and a member of the ETF Capital Markets Group at State Street Global Advisors (2010-2019); and an ETF trader at Goldman Sachs & Co (2005-2010). Mr. Maund graduated with a bachelor’s degree in economics from Wesleyan University.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.01 33.62 6.04 0.33